Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • Phase Ib/II trial of anti-CD33...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

Phase Ib/II trial of anti-CD33 monoclonal antibody BI 836858 and azacitidine in previously untreated older acute myeloid leukemia patients: Beat AML S2 sub-study results

Not available.

Bibliographic Details
Published in:Haematologica
Main Authors: Michael J. Hochman, Amy S. Ruppert, Ying Huang, Alice Mims, Uma Borate, Ronan Swords, Elie Traer, Maria R. Baer, Vu H. Duong, Wendy Stock, Toyosi Odenike, Prapti Patel, Yazan Madanat, Eytan Stein, Michael W. Deininger, Gary Schiller, Daniel A. Pollyea, James M. Foran, Rebecca Olin, Tara Lin, Michael M. Boyiadzis, Shivani Handa, Bjoern Rueter, Theophilus J. Gana, Nyla A. Heerema, Timothy Chen, Molly Martycz, Mona Stefanos, Sonja Marcus, Leonard Rosenberg, Brian Druker, Ross Levine, Amy Burd, Ashley O. Yocum, John C. Byrd, William Blum
Format: Article
Language:English
Published: Ferrata Storti Foundation 2026-04-01
Online Access:https://haematologica.org/article/view/14149
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://haematologica.org/article/view/14149

Similar Items

  • Real‐world genomic testing and treatment patterns of newly diagnosed adult acute myeloid leukemia patients within a comprehensive health system
    by: John C. Byrd, et al.
    Published: (2023-09-01)
  • Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial
    by: Fieke W. Hoff, et al.
    Published: (2025-04-01)
  • P512: A PHASE 1B/2 STUDY OF TP-0903 AND DECITABINE TARGETING MUTANT TP53 AND/OR COMPLEX KARYOTYPE IN PATIENTS WITH UNTREATED ACUTE MYELOID LEUKEMIA (AML) ≥ AGE 60 YEARS: FINAL RESULTS
    by: Alice Mims, et al.
    Published: (2023-08-01)
  • Beat AML genetic risk stratification model in a cohort of older VEN/HMA-treated patients with AML
    by: Fieke W. Hoff, et al.
    Published: (2025-08-01)
  • A phase I/II multicenter, open-label, dose escalation and randomized trial of BI 836858 in patients with low- or intermediate-1-risk myelodysplastic syndrome
    by: Rami S. Komrokji, et al.
    Published: (2022-06-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs